FG-3246 and enzalutamide combination therapy, in biomarker unselected patients with androgen receptor pathway inhibitor (ARPI)-treated, ...

Significantly less progression, especially unstable lesions, with relugolix versus leuprol ...

One type of androgen deprivation therapy may speed coronary plaque growth in men being treated for localized prostate cancer.

Metastasis-directed therapy for oligometastatic prostate cancer was associated with improved outcomes in a systematic review and meta-analysis.

Step by step, little by little, we are learning how to act on this new staging information,’ one investigator says.

When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...

But an association with improved overall survival failed to reach statistical significance ...

The statistics are sobering and undeniable — African American men develop prostate cancer at twice the rate of white men and are more likely to die from the disease. This reality makes understanding ...

Prostate cancer has been one of the major areas of research for radioligand therapies. Last year, Novartis officials estimated that the March 28, 2025, FDA approval for Pluvicto in metastatic ...

While many people are familiar with mammograms and smear tests, prostate screening is talked about far less.To shed light on this important subject ahead of Prostate Cancer Awareness Month in March, ...